Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta-analysis

Respirology

Volumn 19, Issue 7, 2014, Pages 993-998

  Ungprasert, Patompong ^a   Srivali, Narat ^b   Wijarnpreecha, Karn ^c,d   Thongprayoon, Charat ^e   Cheungpasitporn, Wisit ^e   Knight, Eric L ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Cardiac Electrophysiology Unit   (Thailand)

^c Faculty of Medicine Chiang Mai University   (Thailand)

^d Department of Internal Medicine Columbia University College of Phys and Surg ^*  (United States)

^e MAYO CLINIC   (United States)

Author keywords

Epidemiology; Malignancy; Meta analysis; Neoplasm; Sarcoidosis

Indexed keywords

COHORT ANALYSIS; HUMAN; META ANALYSIS; METHODOLOGY; PUBLISHING; REVIEW; RISK FACTOR; SARCOIDOSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; COMPLICATION; INCIDENCE; NEOPLASMS; RISK;

HUMANS; INCIDENCE; NEOPLASMS; ODDS RATIO; SARCOIDOSIS;

EID: 84908617330     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12369     Document Type: Review

References (21)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N. Engl. J. Med. 1997;336:1224-34.
2. Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin. Dermatol. 2007;25:326-33.
3. Pettersson T, Koivunen E, Ilvonen M, Jouppila J, Aalto E, Wasastjerna C. Sarcoidosis and multiple myeloma: an association. Br. Med. J. 1987;295:958.
4. Suen JS, Forse MS, Hyland RH, Chan CK. The malignancysarcoidosis syndrome. Chest 1990;96:1300-1.
5. Rayson D, Burch PA, Richardson RL. Sarcoidosis and testicular carcinoma. Cancer 1998;83:337-43.
6. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur. J. Epidemiol. 2010;25:603-5.
7. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986;7:177-88.
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
9. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann. Oncol. 2009;20:1121-6.
10. Boffetta P, Rabkin CS, Gridley G. A cohort study of cancer among sarcoidosis patients. Int. J. Cancer 2009;124:2697-700.
11. Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir. Med. 2007;101:2534-40.
12. Romer FK, Hommelgaard P, Schou G. Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur. Respir. J. 1998;12:906-12.
13. Seersholm N, Vestbo J, Viskum K. Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997;52:892-4.
14. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am. J. Respir. Crit. Care Med. 1999;160:1668-72.
15. Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br. J. Cancer 1974;29:247-51.
16. Romer FK. Sarcoidosis and cancer-a critical view. In: Jones Williams J, Davies BH (eds) Proceedings of the VIIIth International Conference on Sarcoidosis. Alpha Omega Press, Cardiff, 1980;567-71.
17. Romer FK. Is there any causal relationship between sarcoidosis and malignancy? Sarcoidosis 1990;7:80-4.
18. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Kambouchner M, Valeyre D, Chapelon-Abric C, Debre P et al. The immune paradox of sarcoidosis and regulatoryT cells. J. Exp. Med. 2006;203:359-70.
19. Sharma OP, Lamb C. Cancer in interstitial pulmonary fibrosis and sarcoidosis. Curr. Opin. Pulm. Med. 2003;9:398-401.
20. Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA. Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol. 2013;2013:509354.
21. Gayed M, Bernatsky S, Ramsey-Goldman R, Clarke A, Gordon C. Lupus and cancer. Lupus 2009;18:479-85.